FDA Guidance for Industry: Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities
Titel:
FDA Guidance for Industry: Remote Interactive Evaluations of
Drug Manufacturing and Bioresearch Monitoring Facilities
Internet:
Herkunft/Verlag:
FDA
Inhalt:
FDA is issuing this guidance to describe how we request and conduct voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, compounded, or held, and at drug facilities covered under FDA’s bioresearch monitoring (BIMO) program